Sell-side analysts also estimate mean earnings per share for the year of $3.64, according to the report.
Financial analyst firms have given AmSurg an average price target of $83.63.
More articles on transactions and valuation issues:
Moody’s: Surgery Partners IPO filing is credit positive
SCA stock receives ‘hold’ rating
Q2 industry update: How did ASC companies fare?
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
